Close Menu

distribution agreement

Webb Diagnostic has placed an initial order worth about C$3.5 million for MedMira's RevealCOVID-19 Total Antibody Test.

Todos said it believes that gaining access to a medical grade ventilator will bring further attention to its coronavirus tests.

Medusa19, with an initial focus on home testing, is investing in a global e-commerce infrastructure to prepare for the launch of Avacta’s COVID-19 rapid test.

Swiss firm DKSH will market and sell Ubiquitome's Liberty16 PCR-based platform in Australia, New Zealand, and other countries in the region.

Chembio said the agreement with the Fisher Healthcare channel will provide it with expanded access to hospital and physician office labs in the US.

The point-of-care system is designed to measure glycated hemoglobin levels in whole blood for use in the monitoring and management of diabetes.

The PCR-based tests are designed to detect the SARS-CoV-2 nucleocapsid gene in various respiratory specimens including oropharyngeal swabs.

The deal marks the 10th distribution agreement Australia-based Sienna has signed for its test, including one covering Finland earlier this year.

NG Biotech's COVID-19 NG-Test IgG-IgM test detects and differentiates the presence of isotypes IgG and IgG antibodies to SARS-CoV-2.

SG Blocks said it intends to create SARS-CoV-2 testing facilities using its expertise in building structures from maritime-grade shipping containers.